January 9, 2023
Cambridge, UK: Astrea Bioseparations (“Astrea Bio”), a leading provider of high-quality bioseparation and purification technologies, announced today the acquisition of Delta Precision Ltd. (“Delta Precision”), a premier manufacturer of advanced chromatography columns for the biotechnology and pharmaceutical industries. This strategic acquisition, which follows a long-standing relationship of almost a decade, will allow Astrea Bio to expand [...]
Sampling Human Appoints Bob Englert as Chief Operating Officer
January 9, 2023
The company’s advisory board also expands to include Peter Kuhn, Ph.D., Todd Peterson, Ph.D., and Daniel Lysak, M.D. SAN FRANCISCO -- Sampling Human, Inc., a life science tools company developing single cell technologies, today announced the appointment of Bob Englert as chief operating officer. In this role, Englert will lead the company’s operations, including manufacturing [...]
January 9, 2023
Verogen a proven leader in equipping forensic science laboratories and criminal investigators to use next-generation sequencing (NGS) to gain deeper insights Addition of Verogen strengthens QIAGEN leadership in fast-growing field of Human ID / forensics anchored by sample collection and preparation, genetic testing analysis and workflow automation Deal builds on partnership launched in 2021 to distribute [...]
Quanterix Expands Laboratory Developed Test Menu With Launch Of Neurofilament Light Chain Test
January 9, 2023
New CLIA blood test expands access to important “brain health” biomarker to advance research and clinical care BILLERICA, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced the validation of a Laboratory Developed Test (LDT) to quantitatively measure neurofilament light chain (NfL) in serum [...]
Sampling Human Appoints Bob Englert as Chief Operating Officer
January 9, 2023
The company’s advisory board also expands to include Peter Kuhn, Ph.D., Todd Peterson, Ph.D., and Daniel Lysak, M.D. SAN FRANCISCO -- Sampling Human, Inc., a life science tools company developing single cell technologies, today announced the appointment of Bob Englert as chief operating officer. In this role, Englert will lead the company’s operations, including manufacturing [...]
“GC/ID is the first major breakthrough in GC/MS in decades”
January 7, 2023
GC/ID is fully automated data processing software that provides dramatic improvements for GC/MS qualitative analysis. By incorporating Cerno’s proven TrueCal™ calibration technology for accurate mass formula ID along with conventional library search, a significant improvement in compound ID certainty is achieved on single quad GC/MS systems. GC/ID also provides, for the first time, an entirely automated method [...]
Michelle Quinn Named Acting General Counsel for BD
January 6, 2023
FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that Michelle Quinn has been named acting general counsel of BD, succeeding Samrat (Sam) Khichi, who has informed the company of his intent to depart BD for a new opportunity, effective Feb. 3, 2023. Quinn, 54, will be responsible for [...]
January 6, 2023
Agilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma Applications Will commercialize end-to-end workflow solutions for tissue biomarker analysis in companion diagnostic development SANTA CLARA, Calif, & MARLBOROUGH, Mass.-- Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, to develop multiplex-immunohistochemistry diagnostic solutions [...]
Genomic Vision announces successful beta testing of FiberSmart®
January 5, 2023
• FiberSmart® is Genomic Vision’s Artificial Intelligence (AI) powered and fully integrated software automating genomic analysis • FiberSmart® leverages cutting-edge AI to rapidly analyze DNA replication kinetics and provide a seamless user experience • FiberSmart platform was successfully tested by AstraZeneca and the Fritz Lipmann Institute Bagneux (France) - Genomic Vision (FR0011799907 – GV, – [...]
Metrohm wins award from The National Institute on Drug Abuse (NIDA)
January 5, 2023
Determining Overdose by Surface Enhanced Raman Spectroscopy (DOSERS) Metrohm’s SERS expert and inventor of P-SERS strips, Dr. Wei Yu, has been awarded a grant from the National Institute on Drug Abuse (NIDA) for a portable Raman-based postmortem toxicology screening method. Whole blood screening at the scene Dr. Yu’s powerful platform technology will aid in quick [...]

